Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2025)

Bicycle Therapeutics' EBT Margin history spans 8 years, with the latest figure at 430.75% for Q4 2025.

  • For Q4 2025, EBT Margin fell 298548.0% year-over-year to 430.75%; the TTM value through Dec 2025 reached 9.16%, down 1308.0%, while the annual FY2025 figure was 9.16%, 732.0% down from the prior year.
  • EBT Margin reached 430.75% in Q4 2025 per BCYC's latest filing, up from 501.92% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 3416.24% in Q4 2024 to a low of 2711.75% in Q2 2025.
  • Average EBT Margin over 5 years is 574.57%, with a median of 672.39% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 433124bps in 2024, then tumbled -298548bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 1174.06% in 2021, then skyrocketed by 69bps to 361.88% in 2022, then tumbled by -153bps to 915.01% in 2023, then soared by 473bps to 3416.24% in 2024, then crashed by -87bps to 430.75% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's EBT Margin are 430.75% (Q4 2025), 501.92% (Q3 2025), and 2711.75% (Q2 2025).